IDH1 and central nervous system cancer: In agreement with this, lower quantities of glycolytic intermediates, including fructose 1,6-bisphosphate, 3-phosphoglycerate and phosphoenolpyruvate, have been observed in IDH1 mutant glioma tissue [95].